NXTC Stock Analysis: Buy, Sell, or Hold?
NXTC - NextCure, Inc. Common Stock
$10.72
0.19 (1.80%)
▲
5d:
+5.82%
30d:
-14.92%
90d:
-24.45%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
30d
Get Alerted When NXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NXTC is currently trading at $10.72, which is considered slightly low relative to its 30-day fair value range of $10.40 to $12.90.
Technical Outlook: Technically, NXTC is showing sideways momentum. Immediate support is located at $8.63, while resistance sits at $11.28.
Market Sentiment: NXTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.67 (+64.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NXTC is showing sideways momentum. Immediate support is located at $8.63, while resistance sits at $11.28.
Market Sentiment: NXTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.67 (+64.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$10.40 -
$12.90
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.8% below Wall St target ($17.67)
Fair Price Analysis
30-Day Fair Range
$10.40 -
$12.90
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$8.63
Resistance Level
$11.28
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.70
Wall Street Target
$17.67
(+64.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 05, 2026 9:03 PM ET
Data refreshes hourly during market hours. Next update: 10:03 PM
Data refreshes hourly during market hours. Next update: 10:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 53 HOLD |
